Status:
NOT_YET_RECRUITING
Integrated PET/MR Imaging With Amino Acid Radiotracers in the Evaluation of Brain Neoplasms: Assessing Diagnostic Accuracy and Therapeutic Response
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Primary and Secondary Brain Tumors
Eligibility:
All Genders
18-99 years
Brief Summary
Evaluation of the diagnostic and prognostic role of PET with Amino Acid Radiotracers associated with simultaneous acquisition of MRI with administration of paramagnetic contrast medium based on Gadobu...
Eligibility Criteria
Inclusion
- Age 18-99.
- Diagnosis of primary or secondary brain tumors.
- Development of suspected lesions on MRI following treatment, with dimensions greater than one centimeter.
- Ability to undergo PET/MRI imaging sessions.
- Availability of clinical and follow-up data for correlation with imaging findings
- Signed informed consent from the patient
Exclusion
- .Patients under 18 years of age. 2.Absence of a confirmed diagnosis of primary or secondary brain tumors. 3.Lesions on MRI with dimensions smaller than one centimeter. 4.Inability to undergo PET/MRI imaging sessions (e.g., due to medical conditions such as pregnancy, allergies to contrast agents, or presence of incompatible implants or devices) 5.Unavailability of clinical and follow-up data for correlation with imaging findings.
- Patients who are unable or unwilling to provide signed informed consent.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2031
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT07211360
Start Date
October 1 2025
End Date
September 1 2031
Last Update
October 7 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.